Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
0.8550
Dollar change
-0.0248
Percentage change
-2.82
%
Index- P/E- EPS (ttm)-3.79 Insider Own34.92% Shs Outstand47.69M Perf Week-19.34%
Market Cap54.98M Forward P/E- EPS next Y-0.46 Insider Trans0.00% Shs Float41.84M Perf Month-19.34%
Income-58.20M PEG- EPS next Q-0.24 Inst Own14.12% Short Float2.43% Perf Quarter-58.09%
Sales48.78M P/S1.13 EPS this Y80.95% Inst Trans-6.55% Short Ratio0.77 Perf Half Y-73.03%
Book/sh-1.38 P/B- EPS next Y-4.55% ROA-72.92% Short Interest1.02M Perf Year-91.96%
Cash/sh0.46 P/C1.85 EPS next 5Y- ROE-1715.20% 52W Range0.83 - 10.94 Perf YTD-77.14%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-92.18% Beta-0.30
Dividend TTM- Quick Ratio0.72 Sales past 5Y-5.58% Gross Margin75.38% 52W Low3.01% ATR (14)0.21
Dividend Ex-Date- Current Ratio0.81 EPS Y/Y TTM-1413.99% Oper. Margin-156.77% RSI (14)36.71 Volatility7.31% 24.94%
Employees252 Debt/Eq- Sales Y/Y TTM- Profit Margin-119.31% Recom1.00 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q126.30% Payout- Rel Volume0.15 Prev Close0.88
Sales Surprise2.02% EPS Surprise139.29% Sales Q/Q- EarningsMay 14 BMO Avg Volume1.31M Price0.86
SMA20-35.29% SMA50-42.50% SMA200-69.64% Trades Volume201,203 Change-2.82%
Date Action Analyst Rating Change Price Target Change
Feb-09-24Initiated Jefferies Buy $5
Jul-16-24 04:05PM
Jun-28-24 09:06AM
Jun-26-24 08:36AM
Jun-20-24 03:49PM
08:00AM
01:44PM Loading…
Jun-14-24 01:44PM
Jun-11-24 10:50AM
09:35AM
08:00AM
Jun-05-24 08:00AM
May-30-24 08:00AM
May-29-24 04:05PM
May-15-24 08:00AM
May-14-24 12:53PM
08:00AM
08:00AM Loading…
May-02-24 08:00AM
Apr-30-24 08:30AM
Apr-17-24 08:31AM
Apr-04-24 08:00AM
Mar-21-24 12:53PM
08:00AM
Mar-13-24 08:30AM
Mar-12-24 08:00AM
Mar-04-24 08:30AM
Feb-20-24 04:05PM
Feb-08-24 08:30AM
Jan-29-24 08:00AM
Jan-23-24 09:04AM
08:15AM
Jan-17-24 08:00AM
08:00AM Loading…
Jan-11-24 08:00AM
Jan-08-24 08:00AM
Jan-05-24 08:00AM
Jan-02-24 08:00AM
Nov-13-23 08:00AM
Nov-06-23 04:05PM
08:00AM
Oct-11-23 08:00AM
Oct-04-23 08:00AM
Sep-18-23 08:00AM
Aug-29-23 08:00AM
Aug-28-23 08:00AM
Aug-04-23 01:33PM
Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chardon BenoitChief Commercial OfficerDec 12 '23Option Exercise1.19165,539197,562199,183Dec 14 07:17 PM